Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shexiang Jiegu Capsule is an approved traditional Chinese medicine (TCM) herbal formulation developed and manufactured by Jilin Liaoyuan Yulongyadong Pharmaceutical. The capsule is composed of 22 herbal and mineral ingredients, including artificial musk, notoginseng, dragon's blood, and frankincense. It is pharmacologically designed to disperse blood stasis, alleviate pain, and promote the reunion of fractured bones. Clinically, it is indicated for the treatment of traumatic injuries such as bruises, tendon fractures, sprains, and lower back strains. The product is approved for oral administration in China under the drug approval number Z22023037.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shexiang Jiegu Capsule.